National Comprehensive Cancer Network® Posts New “Patient Friendly” Guidelines for Treatment of Ovarian Cancer.
Women with ovarian cancer now have a new resource that provides them with the same credible information their physicians use when determining treatment options. The National Comprehensive Cancer Network® (NCCN®) announces three new additions to the library of NCCN Guidelines for Patients™, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™). NCCN Guidelines for Patients™: Melanoma, Ovarian Cancer, and Prostate Cancer are now available free of charge at NCCN.com.
The NCCN Guidelines for Patients™ are designed to provide people with cancer and their caregivers with state-of-the-art treatment information in easy-to-understand language. Given the prevalence of melanoma and prostate cancer – both among the most frequently diagnosed cancers in men – and the challenges in detecting ovarian cancer in women, it is critical that patients have resources to empower them to take a more active role in their treatment.
The NCCN Guidelines™ are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or “decision trees” that address every appropriate treatment option from initial work up throughout the course of the disease. The NCCN Guidelines for Patients™ translate these professional guidelines in a clear, step-by-step manner that patients can use as the basis for making decisions and discussing options with their physicians.
The NCCN Guidelines for Patients™ are available free of charge at NCCN.com, which also features additional informative articles for patients and caregivers.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are:
City of Hope Comprehensive Cancer Center, Los Angeles, CA;
Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA;
Duke Comprehensive Cancer Center, Durham, NC;
Fox Chase Cancer Center, Philadelphia, PA;
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT;
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA;
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD;
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL;
Memorial Sloan-Kettering Cancer Center, New York, NY;
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Columbus, OH;
Roswell Park Cancer Institute, Buffalo, NY;
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO;
St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN;
Stanford Comprehensive Cancer Center, Stanford, CA;
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL;
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI;
UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE;
The University of Texas MD Anderson Cancer Center, Houston, TX; and
Vanderbilt-Ingram Cancer Center, Nashville, TN.
- Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN, Press Release, National Comprehensive Cancer Network (www.NCCN.org), January 5, 2011.
- Ovarian Cancer, NCCN Guidelines For Patients™ (Version 2010)(Adobe Reader PDF document).